Sign In

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.


Erasmus MC Biomedical Fund co-founds and finances biotech spinout Therosteon

Press Release – For Immediate Release

Rotterdam, April 1, 2008 – the Erasmus MC Biomedical Fund is pleased to announce the successful spin-out and financing of a new biotech company, Therosteon B.V.

Therosteon is a spin-off company from the Erasmus University Medical Center in Rotterdam. Its goal is to further develop novel therapies for bone diseases. Therosteon’s technology is based on a proprietary drug development platform, which enables the company to generate new drug targets and therapies for a variety of bone diseases, including osteoporosis and bone metastasis. Therosteon’s scientific founder is Hans van Leeuwen, Professor at the Department of Internal Medicine of the Erasmus MC and expert in the field of bone diseases and vitamin D biology.

Therosteon secured start-up financing from the Erasmus MC Biomedical Fund. In addition, the company has received an incubator investment from the Technology Transfer Office of the Erasmus MC and is preparing for a larger financing round later this year.

About Erasmus MC Biomedical Fund
The Erasmus MC Biomedical Fund is an independent venture capital fund focusing on early stage companies and (university) spin-outs in the biotechnology and biomedical field with a presence in the Rotterdam region. The fund targets companies that are developing commercially promising products and technologies in life sciences, including pharmaceuticals, biotechnology, information technology and other high technology opportunities that offer venture capital returns. Please visit

Note for the editor:

For further information please contact: Erasmus MC Biomedical Fund, Harm de Vries, telephone: +31 (0)6 – 53216339, e-mail:

Publisher Contact Information:

+31 (0)6 – 53216339

Company profile of Therosteon
Past press releases of Therosteon.


Tech investments
From our Online Data Service
VC-backed companies
From our Radar

Recent Deals

Nov 25€24.0MInternet commerce
Feb 21€87.0MInternet services
Feb 21€18.0MInternet commerce
Feb 20€4.3MSoftware development
Feb 19€0.4MInternet commerce
Feb 19€8.4MMedical devices
Feb 18€25.0MBiotechnology

For information on Europe's most extensive database on technology funding click here!


Press Releases

May 28
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
nethone raised over $1 million from innovation nest

Jan 29
yumpingo raises $10m to transform guest experiences in restaurants

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

About usContact usLegal Information
Copyright © 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.